Ameriprise Financial Inc. Lowers Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Ameriprise Financial Inc. decreased its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 6.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 585,218 shares of the medical instruments supplier's stock after selling 41,911 shares during the period. Ameriprise Financial Inc. owned 2.39% of ICU Medical worth $90,804,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. Freestone Grove Partners LP purchased a new position in ICU Medical during the fourth quarter worth $368,000. Northern Trust Corp increased its position in ICU Medical by 11.1% during the fourth quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier's stock worth $62,431,000 after buying an additional 40,187 shares in the last quarter. Quarry LP increased its position in ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock worth $38,000 after buying an additional 214 shares in the last quarter. Three Seasons Wealth LLC purchased a new position in ICU Medical during the fourth quarter worth $291,000. Finally, Two Sigma Securities LLC purchased a new position in ICU Medical during the fourth quarter worth $229,000. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Trading Up 4.4%

ICUI stock traded up $6.04 during trading on Monday, reaching $144.34. 366,510 shares of the stock traded hands, compared to its average volume of 275,107. The business's 50 day moving average price is $140.67 and its 200-day moving average price is $154.99. ICU Medical, Inc. has a 52-week low of $100.91 and a 52-week high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm has a market capitalization of $3.55 billion, a PE ratio of -31.58 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. The firm had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. During the same quarter in the previous year, the business earned $0.96 earnings per share. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. As a group, sell-side analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have recently commented on ICUI. Raymond James lowered their price objective on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research report on Friday. KeyCorp lowered their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. StockNews.com downgraded ICU Medical from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $192.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.